Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 574)
Posted On: 08/14/2023 10:38:42 AM
Post# of 153994
Posted By: Enjay
Re: KenChowder #136652
Ken, I looked at Jonah's bio on the OHSU website and saw 5 publications they co-authored, but it did not include the one you linked. This connection is lining up quite well.

Jonah's bio
https://www.ohsu.edu/people/jonah-b-sacha-phd

Here are the five publications where both are listed as two of the co-authors (which includes one ohm previously mentioned):

Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission
Nature Communications Dec 1, 2021

HLA-E-restricted, Gag-specific CD8+T cells can suppress HIV-1 infection, offering vaccine opportunities
Science immunology Mar 2021

Identification and Characterization of Antigen-Specific CD8+ T Cells Using Surface-Trapped TNF-a and Single-Cell Sequencing
Journal of Immunology Dec 15, 2021

Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy
Science Apr 30, 2021

The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques
PLoS Pathogens 2020













(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site